San Diego, CA, December 18, 2013 --(PR.com
)-- Stephen Groft, Director of the Office of Rare Diseases Research at the National Institutes of Health, will give a keynote presentation at the Inaugural Cell and Gene Therapy Conference on February 20-21, 2014 in San Diego, CA by GTC.
Dr. Groft’s major focus is on stimulating research with rare diseases and developing information about rare diseases and conditions for health care providers and the public. To help identify research opportunities and establish research priorities, the Office has co-sponsored over 1200 rare diseases-related scientific conferences with the NIH research Institutes and Centers and the extramural research community, including patient advocacy groups. Dr. Groft’s presentation will focus on gene therapy for rare genetic diseases.
Treatment of disease using cell and gene therapy is now a reality. With emerging technologies and new clinical trials being developed and launched at a growing rate, it is important to stay up-to-date with the evolving regulatory challenges and pre-clinical requirements for drug development and discovery. GTC’s Cell and Gene Therapy Conference brings together experts from industry and academia to discuss the development and applications of cell and gene therapy as well as strategies and challenges for commercialization.
This conference is also part of the Future Biotech Summit 2014, which consists of this conference, and two other additional co-located conferences:
2nd Orphan Drugs Research & Commercialization
Ubiquitin Research & Drug Discovery
For more information, please visit www.gtcbio.com